These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 17092192)

  • 41. The evidence-based pharmacotherapy of social anxiety disorder.
    Blanco C; Bragdon LB; Schneier FR; Liebowitz MR
    Int J Neuropsychopharmacol; 2013 Feb; 16(1):235-49. PubMed ID: 22436306
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice.
    Goodwin G; Fleischhacker W; Arango C; Baumann P; Davidson M; de Hert M; Falkai P; Kapur S; Leucht S; Licht R; Naber D; O'Keane V; Papakostas G; Vieta E; Zohar J
    Eur Neuropsychopharmacol; 2009 Jul; 19(7):520-32. PubMed ID: 19411165
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Social anxiety and functional impairment in patients seeking surgical evaluation for hyperhidrosis.
    Schneier FR; Heimberg RG; Liebowitz MR; Blanco C; Gorenstein LA
    Compr Psychiatry; 2012 Nov; 53(8):1181-6. PubMed ID: 22682780
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The development of clonazepam as a psychotropic: the massachusetts general hospital experience.
    Rosenbaum JF
    J Clin Psychiatry; 2004; 65 Suppl 5():3-6. PubMed ID: 15078111
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of serotonin drugs in the treatment of social phobia.
    Tancer ME; Uhde TW
    J Clin Psychiatry; 1997; 58 Suppl 5():50-4. PubMed ID: 9184626
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Social phobia: everyone's disorder?
    Jefferson JW
    J Clin Psychiatry; 1996; 57 Suppl 6():28-32. PubMed ID: 8647795
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differences in clinical presentation between depressed outpatients wanting versus not wanting treatment for comorbid social anxiety disorder.
    Dalrymple KL; Zimmerman M
    J Nerv Ment Dis; 2008 Aug; 196(8):639-42. PubMed ID: 18974677
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clonazepam as a therapeutic adjunct to improve the management of depression: a brief review.
    Morishita S
    Hum Psychopharmacol; 2009 Apr; 24(3):191-8. PubMed ID: 19330803
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clonazepam in the treatment of psychiatric disorders: an update.
    Nardi AE; Perna G
    Int Clin Psychopharmacol; 2006 May; 21(3):131-42. PubMed ID: 16528135
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Novel treatment approaches for refractory anxiety disorders.
    Pollack MH; Otto MW; Roy-Byrne PP; Coplan JD; Rothbaum BO; Simon NM; Gorman JM
    Depress Anxiety; 2008; 25(6):467-76. PubMed ID: 17437259
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A review of 19 double-blind placebo-controlled studies in social anxiety disorder (social phobia).
    Versiani M
    World J Biol Psychiatry; 2000 Jan; 1(1):27-33. PubMed ID: 12607230
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacological treatment of social anxiety disorder.
    Masdrakis VG; Turic D; Baldwin DS
    Mod Trends Pharmacopsychiatry; 2013; 29():144-53. PubMed ID: 25225024
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The pharmacotherapy of social phobia.
    Pollack MH; Gould RA
    Int Clin Psychopharmacol; 1996 Jun; 11 Suppl 3():71-5. PubMed ID: 8923113
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High-potency benzodiazepines: recent clinical results.
    Moroz G
    J Clin Psychiatry; 2004; 65 Suppl 5():13-8. PubMed ID: 15078113
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Defining an appropriate management strategy for social anxiety disorder.
    Davidson JR
    Int Clin Psychopharmacol; 2000 Jul; 15 Suppl 1():S13-7. PubMed ID: 10994678
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hyperhidrosis in social anxiety disorder.
    Davidson JR; Foa EB; Connor KM; Churchill LE
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Dec; 26(7-8):1327-31. PubMed ID: 12502021
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A review of the epidemiology and approaches to the treatment of social anxiety disorder.
    Sareen L; Stein M
    Drugs; 2000 Mar; 59(3):497-509. PubMed ID: 10776832
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Korean Guidelines for the Pharmacological Treatment of Social Anxiety Disorder: Initial Treatment Strategies.
    Yoon H; Oh DJ; Suh HS; Lee KU; Lim SW; Lee JY; Yang JC; Lee JH; Ha J; Lee BH; Kang SG; Yoon HK; Moon J; Bae SM; Kwon Y; Kim HC; Oh KS
    Psychiatry Investig; 2018 Feb; 15(2):147-155. PubMed ID: 29475215
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Current pharmacological interventions in panic disorder.
    Freire RC; Machado S; Arias-Carrión O; Nardi AE
    CNS Neurol Disord Drug Targets; 2014; 13(6):1057-65. PubMed ID: 24923349
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An evaluation of paroxetine in generalised social anxiety disorder.
    Van Ameringen M; Mancini C; Patterson B; Bennett M
    Expert Opin Pharmacother; 2005 May; 6(5):819-30. PubMed ID: 15934907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.